Gerd Wohlfahrt

Years Active: 2017-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela, Marcin Chrusciel, Stefan Karlsson, Petteri Rummakko, Outi Simola, Gerd Wohlfahrt, Pasi Hakulinen, Annamari Vuorela, Heikki Joensuu, Tapio Utriainen, Karim Fizazi, Riikka Oksala
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis. Molecular cancer therapeutics 21 (12) (2022)
Tim H Holmström, Anu-Maarit Moilanen, Tarja Ikonen, Mari L Björkman, Tero Linnanen, Gerd Wohlfahrt, Stefan Karlsson, Riikka Oksala, Timo Korjamo, Susanta Samajdar, Srinivasan Rajagopalan, Shekar Chelur, Kishore Narayanan, Raghuveer K Ramachandra, Jiju Mani, Rashmi Nair, Nagaraj Gowda, Thomas Anthony, Samiulla Dhodheri, Subhendu Mukherjee, Ravi K Ujjinamatada, Srinivas Nanduri, Murali Ramachandra, Pekka J Kallio
ODM-203, a Selective Inhibitor of FGFR and VEGFR, Shows Strong Antitumor Activity, and Induces Antitumor Immunity. Molecular cancer therapeutics 18 (1) (2018)
Vigneshwari Subramanian, Qurrat Ul Ain, Helena Henno, Lars-Olof Pietilä, Julian E Fuchs, Peteris Prusis, Andreas Bender, Gerd Wohlfahrt
3D proteochemometrics: using three-dimensional information of proteins and ligands to address aspects of the selectivity of serine proteases. MedChemComm 8 (5) (2017)

Gerd Wohlfahrt.css-eqlu8i{font-size:small;padding-left:4px;}